Premium
Hepatitis C virus nonstructural protein 5A inhibitors: Novel target—Now for new trials and new treatment strategies
Author(s) -
Thompson Alex J.,
Clark Paul J.,
McHutchison John G.
Publication year - 2010
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.23853
Subject(s) - ns5a , ns5b , hepatitis c virus , ribavirin , virology , ns3 , virus , replicon , hepacivirus , biology , pegylated interferon , telaprevir , genotype , protease inhibitor (pharmacology) , sofosbuvir , hepatitis c , viral load , genetics , dna , gene , antiretroviral therapy , plasmid
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom